Volpara to present at RSNA 2014 next generation of VolparaAnalytics.
Volpara will showcase at RSNA 2014 VolparaAnalytics version 1.2.
Volpara Analytics is a centralized dashboard that presents key mammography metrics and automatically collates data from digital mammography and tomosynthesis units to enable cross-comparison of patient populations, mammography systems, and operator performance, Volpara said.
The new version of VolparaAnalytics will feature an enhanced user interface and reporting tools, and deliver expanded breast imaging metrics to users including additional quality metrics, new temporal analysis tools, additional tools to analyze patient positioning and patient dose, and time between study acquisition, Volpara said.
VolparaAnalytics runs on top of VolparaDensity, a software tool that helps radiologists objectively assess density from both digital mammography and tomosynthesis images and determine which women would benefit from additional screening.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.